| PLAUR antibodies | |
| This is a review about PLAUR antibodies, based on 9 published articles using PLAUR antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited PLAUR antibody. Information in this review (with links to publications) can be searched freely. |
BD BIOSCIENCES search BD Biosciences PLAUR products
includes other brands or spellings
|
| flow, wb | | BD Pharmingen monoclonal anti-human uPAR antibody VIM5 was used in human HEK-293 cells (which was transfected uPAR cDNA) and in flow cytometry, western blot to study the role of sequences within domain II of the urokinase receptor for differential ligand recognition. |
| flow | | BD Biosciences anti-CD87 monoclonal antibody Vim 5 was used in flow cytometry to study the biological function of calreticulin. |
AMERICAN DIAGNOSTICA search American Diagnostica PLAUR products
|
| block | | American Diagnostica monoclonal anti-uPAR antibody (#3936) was used in human cells andin blocking expriments to study the effect of the binging of PAI-1 to the Tbeta4-activated endothelial cells on their fibrinolytic potential. |
| elisa, wb | | American Diagnostica rabbit polyclonal anti-human uPAR (399R) antibody, monoclnal anti-human uPAR antibody (3931, 3932, 3936, 3937) and monoclnal anti-human uPAR antibody (3471) were used in human HEK-293 cells (which was transfected uPAR cDNA) and were respectively used in flow cytometry and ELISA, blocking experiments to study the role of sequences within domain II of the urokinase receptor for differential ligand recognition. |
| ic, ip | | American Diagnostica rabbit polyclonal anti-uPAR antibody 399 was used in human embrional kidney 293 (HEK-293) cells (which was transfected uPAR cDNA) and in immunoprecipitation, immunocytochemistry to study the effect of the cleavage of the urokinase receptor on its multiple functions. |
| ip, wb | | American Diagnostica rabbit anti-uPAR polyclonal antibody was used in western blot and immunoprecipitation to study the uPAR is anchored to the Actin Cytoskeleton by Urokinase. |
| ip | | American Diagnostica anti-uPAR polyclonal antibody 399R was used in immunoprecipitation to study urokinase receptor modulation by the tetraspanin CD82. |
| wb | | American Diagnostica anti-uPAR antibody was used in western blot to study the mitogenic activity of urokinase-type plasminogen activator which is determined by the dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex. |
| wb | | American Diagnostica monoclonal antibody to uPAR was used in western blot to study the effect of pathogenic Abeta deposition on the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. |
AMERICAN DIAGNOSTICS
|
| ih, wb | | American Diagnostics anti-uPAR antibody was used in western blot and immunohistochemistry to study the effect of uPA on prostate cancer cell invasion, survival, and tumorigenicity in vivo. |
Articles Reviewed |
| 1. Nunzia Montuori et al. The cleavage of the urokinase receptor regulates its multiple functions. 2002 |
| 2. Ionita Ghiran et al. Calreticulin is at the surface of circulating neutrophils and uses CD59 as an adaptor molecule. 2003 |
| 3. Judianne Davis et al. Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. 2003 |
| 4. Yang Li et al. Sequences within domain II of the urokinase receptor critical for differential ligand recognition. 2003 |
| 5. Audrey M Bernstein et al. Urokinase anchors uPAR to the actin cytoskeleton. 2004 |
| 6. Rosemary Bass et al. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. 2005 |
| 7. Minji Jo et al. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. 2005 |
| 8. Sai MuraliKrishna Pulukuri et al. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. 2005 |
| 9. Joanna Boncela et al. Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential. 2006 |
|